Related Experiment Videos
Electrocardiographic and vectorcardiographic abnormalities in Fabry's disease
American Heart Journal
|June 1, 1977
Summary
Fabry disease commonly causes cardiac abnormalities, including conduction defects and chamber enlargement, due to lipid infiltration. Early recognition of these ECG findings is crucial for potential Fabry disease therapy.
Area of Science:
- Cardiology
- Genetics
- Rare Diseases
Background:
- Fabry disease is a rare genetic disorder characterized by glycosphingolipid accumulation.
- Cardiac involvement is a known complication of Fabry disease, but specific ECG findings require further elucidation.
Purpose of the Study:
- To investigate the spectrum and prevalence of electrocardiographic (ECG) abnormalities in patients with Fabry disease.
- To correlate ECG findings with disease duration, genotype (hemizygosity vs. heterozygosity), and potential underlying pathology.
Main Methods:
- Retrospective analysis of ECG and vectorcardiography (VCG) data from 32 patients with Fabry disease.
- Evaluation of rhythm, PR interval, conduction abnormalities, chamber size, and ST-T wave changes.
- Correlation of findings with clinical data, including disease duration and genetic status.
Main Results:
- Abnormal rhythms were observed in a subset of patients, with some developing over time.
- Short PR intervals (≤120 msec) and prolonged PR intervals (<140 msec) were noted.
- Conduction abnormalities, particularly intraventricular defects progressing to right bundle branch block, affected 22% of patients.
- Atrial or ventricular enlargement occurred in 60%, with left ventricular hypertrophy being most common.
- ST-T changes and one case of anterior myocardial infarction pattern were observed.
- Hemizygosity was associated with a higher burden of cardiac abnormalities compared to heterozygosity.
- Conduction defects worsened with longer disease duration.
- VCG provided no significant additional information beyond standard ECG.
Conclusions:
- Fabry disease frequently manifests with diverse ECG abnormalities, including conduction disturbances and chamber enlargement, likely due to lipid infiltration of the myocardium and conduction system.
- Recognizing these cardiac manifestations is vital for timely diagnosis and management of Fabry disease, as therapeutic interventions may be possible.
- Standard ECG is effective in detecting cardiac involvement in Fabry disease, with VCG offering limited added value.